Javascript is required for this site to function correctly.
Please enable Javascript support.

MJFF In The News

|
|
|
2006
|
|
|
Descending
|

12/14/2006 Michael J. Fox Foundation Awards $1.5 Million under Community Fast Track 2006

13 national and local Parkinson's organizations take advantage of generous challenge grant in joining with Foundation to fund program

12/11/2006 Foundation Commits up to $10 Million for LEAPS 2007 Initiative

12/08/2006 Accepting the Risk in Hopes of a Cure

In a partnership with The Michael J. Fox Foundation, San Diego biotech Ceregene Inc. initiates the Phase II trial of CERE-120, a novel gene therapy product that has shown potential in preclinical trials to slow or stop the progression of Parkinson's disease.

11/26/2006 No Exaggeration: Parkinson's Offers Lessons

The Westchester edition of Sunday's New York Times featured a column on David Eger, founder of Music for Parkinson's Research, one of largest community fundraisers that benefits The Michael J. Fox Foundation.

11/16/2006 Foundation Awards $2.3 Million to Develop Treatments for Dopamine-Non-Responsive Symptoms of PD

11/14/2006 Foundation Launches $2.8-Million Prescott Family Initiative at the Arizona Parkinson's Disease Consortium

Collaboration could lead to better understanding and earlier diagnosis of PD

11/13/2006 Legendary Rockers Bring Down the House at Foundation's 'Funny Thing' Gala

The Michael J. Fox Foundation raised nearly $5.7 million for Parkinson’s research at the star-studded sixth installment of its gala event, "A Funny Thing Happened on the Way to Cure Parkinson's," held Saturday, November 11, 2006.

11/02/2006 Marathoners Join Team Fox in the Race to Find A Cure for Parkinson's

10/24/2006 SAVE THE DATE: Overcoming Barriers to Successful Demonstration of Therapeutic Disease Modification -- February 21-22, 2007

The Michael J. Fox Foundation will host a satellite meeting to ISCTM's Third Annual Meeting, to be held in February 2007.

10/17/2006 Gene Therapy Trials Show Promise against Parkinson's

Two Phase I safety studies of human gene therapy for Parkinson's disease have shown that the technique is safe and may reduce symptoms for patients.

10/12/2006 Foundation Launches Parkinson's Genetics Database PDGene

10/11/2006 Michael J. Fox Foundation and Elan Commit up to $2 Million to Drive Novel Therapies for Parkinson's

10/10/2006 Foundation Awards $1.9 Million to Support Ceregene Phase II Gene Therapy Clinical Trial

Funding follows on promising early results of Phase I trial

10/04/2006 Foundation Seeks Novel Drug Development Strategies for 2007 Target Validation Initiative

09/26/2006 Foundation Commits Up to $1 Million to Characterize Parkinson's Disease Subtypes

09/18/2006 Golfers Tee Up to "Break PARkinson's"

08/11/2006 Hedge Fund Manager Who Plays His Cards Right

After entering the World Series of Poker in Las Vegas, the game’s most prominent tournament, on a whim, Michael J. Fox Foundation Board member David Einhorn came in 18th place this week, winning more than $650,000 -- winnings he has announced he will donate to the Foundation.

08/11/2006 TIVO Alert!

08/08/2006 Strong Evidence of a Genetic Risk Factor for Parkinson's Disease

A Mayo Clinic-led international research collaboration supported by The Michael J. Fox Foundation's Edmond J. Safra Global Genetics Consortia provides strong evidence that a genetic risk factor may account for 3 percent of the cause of Parkinson's disease.

08/08/2006 The Foundation Thanks David Einhorn for Donating His Winnings From the World Series of Poker

David Einhorn has just raised $659,730 for The Michael J. Fox Foundation by finishing 18th in the World Series of Poker’s main event. Einhorn sits on the Foundation's board and planned from day one of the main event to donate all his winnings to the nonprofit organization.

07/19/2006 Run Like a Fox on November 5, 2006

The Michael J. Fox Foundation is honored to be a part of the ING New York City Marathon's expanded charity program. Team Fox has a limited number of guaranteed entries available for this year's race.

07/18/2006 Michael J. Fox Urges President Bush to Sign the Stem Cell Research Enhancement Act (H.R. 810)

06/27/2006 Foundation Awards $2.6 Million for Development of Progressive Animal Models of Parkinson's Disease

06/06/2006 Foundation Awards $1.8 Million for Translational Research under 2006 Target Validation Initiative

05/04/2006 Foundation's Second L.A. Event Raises $1.2 Million for Parkinson's Research

04/27/2006 Seven Clinical Studies to Receive $3.7 Million under Foundation's 2006 Clinical Discovery Program

04/26/2006 Team Fox Raises Awareness and Funds for Parkinson's Research

04/16/2006 Read Michael J. Fox's Inspiring Interview with DATELINE

DATELINE(NBC) recently featured an hour-long program dedicated to Parkinson's disease. During the show, Katie Couric interviewed Michael J. Fox and discussed the role he and the Foundation play in the fight against the disease.

04/10/2006 Foundation Launches $5 Million Industry-focused Therapeutics Development Initiative

03/30/2006 Michael J. Fox Foundation Seeks Innovative Scientific Approaches for 2006 Community Fast Track Program

Foundation Reaches Out to Parkinson's Community to Support $2 Million Effort

03/20/2006 Michael J. Fox Foundation Announces Funding for California Parkinson's Disease Registry Pilot Project

Stakeholders'? Meeting to be Held on March 28th in Oakland, California

03/13/2006 Foundation to Award Up To $2 Million to Address

02/22/2006 Michael J. Fox's Welcoming Remarks at Inaugural World Parkinson Congress

Michael J. Fox delivered inspiring welcoming remarks to an audience of over 2,000 at the inaugural World Parkinson Congress in Washington, DC.

02/21/2006 Foundation Awards $1.9 Million through Community Fast Track 2005

12 national and local Parkinson's groups join The Michael J. Fox

02/17/2006 Eugene Johnson, PhD, to Serve as MJFF Chief Scientific Advisor

02/13/2006 Foundation to Provide Up to $3.1 Million for Development of New Therapy to Stop Parkinson's Progression

01/05/2006 Foundation to Provide Up to $4.2 Million for Development of Regulatable Gene Therapy Vector

"RheoSwitch(R) Therapeutic System" Broadly Applicable to Gene Therapy

Print This Page Email This Page